Literature DB >> 8031327

Chronic eosinophilic pneumonia. A long-term follow-up of 12 patients.

M Naughton1, J Fahy, M X FitzGerald.   

Abstract

Chronic eosinophilic pneumonia (CEP) is a rare disorder of unknown etiology characterized by striking systemic and pulmonary manifestations such as fever, weight loss, blood eosinophilia, characteristic fluffy peripheral opacities on chest radiograph, and a prompt response to corticosteroid therapy. While the initial phase has been well documented, there is very limited information concerning the long-term natural history and treated course of this condition. We report the clinical and laboratory findings together with the long-term follow-up data on 12 patients with classic CEP who were followed up for a mean of 10.2 years (range, 4 to 13 years). The most striking feature of the long-term follow-up was the occurrence of relapses of CEP (often on multiple occasions) when corticosteroid therapy was discontinued or the dose was tapered. In those nine patients in whom steroid withdrawal was commenced, there was a clinical, hematologic, and radiologic relapse in seven (58 percent). However, prompt reinstitution of therapy led to a rapid resolution of symptoms. By contrast, two patients (17 percent) showed no evidence of relapse when steroid therapy was discontinued. A further three patients (25 percent) are maintained on a regimen of low-dose steroid therapy with no episodes of relapse. Reassuringly, all 12 patients are well at the end of a long period of follow-up. These data suggest that the long-term prognosis for patients with CEP is excellent but the majority will require long-term low-dose oral corticosteroid therapy in order to prevent relapse.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8031327     DOI: 10.1378/chest.103.1.162

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  19 in total

1.  Eosinophilic Lung Disease: Accompanied with 12 Cases.

Authors:  Tülin Sevim; Emine Aksoy; Fatma Tokgöz Akyıl; Meltem Çoban Ağca; Nilüfer Aykaç Kongar; Ferhan Özşeker
Journal:  Turk Thorac J       Date:  2015-10-01

2.  Chronic eosinophilic pneumonia with persistent decreased diffusing capacity for carbon monoxide.

Authors:  Sibylle Blanc; Marc Albertini; Sylvie Leroy; Lisa Giovannini-Chami
Journal:  BMJ Case Rep       Date:  2013-02-15

3.  Chronic eosinophilic pneumonia: a paediatric case.

Authors:  Davide Tassinari; Chiara Di Silverio Carulli; Francesca Visciotti; Roberta Petrucci
Journal:  BMJ Case Rep       Date:  2013-04-25

4.  Successful treatment of acute relapse of chronic eosinophilic pneumonia with benralizumab and without corticosteroids: A case report.

Authors:  Shimon Izhakian; Barak Pertzov; Dror Rosengarten; Mordechai R Kramer
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

Review 5.  Eosinophilic pneumonias.

Authors:  Praveen Akuthota; Peter F Weller
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

6.  Chronic eosinophilic pneumonia in a 13-year-old child.

Authors:  Nadia Nathan; Nathalie Guillemot; Guillaume Aubertin; Sylvain Blanchon; Katarina Chadelat; Ralph Epaud; Annick Clément; Brigitte Fauroux
Journal:  Eur J Pediatr       Date:  2008-01-17       Impact factor: 3.183

Review 7.  Idiopathic chronic eosinophilic pneumonia.

Authors:  Eric Marchand; Jean-François Cordier
Journal:  Orphanet J Rare Dis       Date:  2006-04-06       Impact factor: 4.123

8.  [Idiopathic chronic eosinophilic pneumonia - a diagnostic challenge].

Authors:  Ertunc Altiok; Rolf Kemper; Joachim Kindler
Journal:  Med Klin (Munich)       Date:  2009-07-18

9.  Successful treatment of chronic eosinophilic pneumonia with anti-IgE therapy.

Authors:  Yoo Seob Shin; Hyun Jung Jin; Hye-Soo Yoo; Eui-kyung Hwang; Young Hee Nam; Young-Min Ye; Hae-Sim Park
Journal:  J Korean Med Sci       Date:  2012-10-02       Impact factor: 2.153

10.  Idiopathic eosinophilic pneumonia in children: the French experience.

Authors:  Lisa Giovannini-Chami; Alice Hadchouel; Nadia Nathan; Francois Brémont; Jean-Christophe Dubus; Michael Fayon; Véronique Houdouin; Michèle Berlioz-Baudoin; Virginie Feret; Thierry Leblanc; Karine Morelle; Marc Albertini; Annick Clement; Jacques de Blic
Journal:  Orphanet J Rare Dis       Date:  2014-02-20       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.